COMPETE Phase III Trial - Peptide Receptor Radionuclide Therapy (PRRT) with Lu-177-Edotreotide vs. Everolimus in Progressive GEP-NET. Wahba, M. M., Strosberg, J., Avram, A., Aparici, C. AMER ASSOC CANCER RESEARCH. 2021

View details for Web of Science ID 000680263501366